BioMarin's CEO On Its Product Pipeline
3.5: Testimony from Jean-Jacques Bienaimé (CEO - BioMarin Pharmaceutical) - Unit 3: Investing in Europe | Coursera
EX-99.1
BioMarin CEO: up to $3 Million Hemophilia Treatment Would Lower Costs
Jean-Jacques Bienaime, Chief Executive Officer and Board of Director, BioMarin Pharmaceutical
Forbes India - BioMarin: One Of The World's Most Valuable Biotechs
Jean Jacques Bienaime – North Bay Leadership Council
About Us - BioMarin
BioMarin expands Cork site to 20 acres
On the Line: BioMarin Pharma's CEO Jean Jacques Bienaime
Gillian Kelly on Twitter: "Jean-Jacques Bienaime, CEO BioMarin at official opening of new facility in Shanbally, Cork http://t.co/4sBFgRPi2v" / Twitter
BioMarin announces second-quarter results, optimism about drug to treat dietary condition
BioMarin Pharmaceutical Inc - Jean-Jacques Bienaimé Chairman and Chief Executive Officer
BioMarin Scores a First Day After Filing Trade Secrets Lawsuit | BioSpace
企業情報 - バイオマリンとは - BioMarin Pharmaceutical Japan
Jean-Jacques Bienaimé - Chairman & CEO at BioMarin Pharmaceutical | The Org
6 January 2015 Jean-Jacques Bienaimé Chief Executive Officer BioMarin Pharmaceutical Inc. - BioMarin Pharmaceutical Inc. - EX-99.(A)(5)(I) - January 06, 2015
Jean-Jacques Bienaime Net Worth (2022) | wallmine
BioMarin CEO has email meltdown, calls terminal cancer patient a "spoiled petulant brat"
BioMarin Pharmaceutical Inc - Jean-Jacques Bienaimé Chairman and Chief Executive Officer
6 January 2015 Jean-Jacques Bienaimé Chief Executive Officer BioMarin Pharmaceutical Inc. - BioMarin Pharmaceutical Inc. - EX-99.(A)(5)(I) - January 06, 2015
The Rocky Journey To Refocusing BioMarin
Biogen vs BioMarin Pharmaceutical Inc. | Comparably
BioMarin Pharmaceutical (NASDAQ: BMRN) wins FDA approval for $700,000 Batten disease drug Brineura - San Francisco Business Times
15. Jean-Jacques Bienaimé | FiercePharma
企業情報 - バイオマリンとは - BioMarin Pharmaceutical Japan
